Skin cancer is one of the most common types of cancer in the United States and one of the most common cancers in the world. Treatment possible with early diagnosis Thousands of people die every year from skin cancer.

Miami-based DermaSensor’s new detection device, powered by artificial intelligence, is major forms of skin cancer, including melanoma This allows an important step to be taken in early diagnosis.

Provides results in seconds with a simple scan

DermaSensor is a very practical device that can be used in the hand. Doctors only need to scan lesions on the skin using the device. DermaSensor then analyzes the obtained data, It provides an initial assessment in seconds. Doctors who use it can request details and, if desired, have a specialist view the results.

In this way, the aim is to strengthen the ability of doctors, especially those working in primary care, to detect skin cancer. The aim is to then transfer patients diagnosed with cancer to specialist services such as dermatology and oncology. Short, Skin cancer can be easily detected even in a family health center.

So how does the device work?

DermaSensor emits light when it comes into contact with the skin and is reflected by the cell structures beneath the skin’s surface. It captures and analyzes the wavelengths of light. Thanks to the algorithm it uses, the system immediately evaluates the data and produces the results within seconds.

FDA approval indicates the device will be used to detect skin cancer. It has a sensitivity of 96% It is based on research that shows this. The percentage of benign results in negative results is announced as 97% according to DermaSensor.

The device, which is also commercially available in Australia and Europe, is based on the device’s subscription model. $199 per month for five patients or $399 per month for unlimited use One of the information shared is that there will be prizes.